Eisai
4523.T
#2149
Rank
HK$73.16 B
Marketcap
HK$259.56
Share price
1.81%
Change (1 day)
16.58%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2025 (TTM): HK$6.78

According to Eisai's latest financial reports the company's current EPS (TTM) is HK$6.78. an increase over its 2024 EPS that were of HK$7.64.

EPS history for Eisai from 2000 to 2025

Annual EPS

Year EPS Change
2025HK$8.5411.85%
2024HK$7.64-32.63%
2023HK$11.345.52%
2022HK$10.74-74.01%
2021HK$41.34-66.58%
2020HK$123.6798.24%
2019HK$62.3817.01%
2018HK$53.3137.78%
2017HK$38.70-27.62%
2016HK$53.4635.33%
2015HK$39.51-2.82%
2014HK$40.65-27.66%
2013HK$56.20-27.49%
2012HK$77.51-12.67%
2011HK$88.7688.08%
2010HK$47.19-11.06%
2009HK$53.06-390.15%
2008-HK$18.29-127.78%
2007HK$65.8411.78%
2006HK$58.904.38%
2005HK$56.437.4%
2004HK$52.5543.03%
2003HK$36.7425.09%
2002HK$29.3752.67%
2001HK$19.2469.76%
2000HK$11.33